Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

128 CIPROFLOXACIN
Purpura
(2006): Urbina F+, Photodermatol Photoimmunol Photomed
22(2), 111
(2002): Mouraux A+, Rev Neurol (Paris) 158(11), 1115
(1999): Goldberg EI+, J Clin Dermatol 2, 25
(1997): Sapadin A+, New York, American Academy of
Dermatology Meeting (SF), Poster #110
(1994): Gamboa F+, Ann Pharmacol 29, 84
Rash (sic) (1–10%)
(2006): Matsuoka H+, Leuk Lymphoma 47(8), 1618
(2000): Johansson A+, Pediatr Infect Dis J 19, 449
(2000): Talan DA+, JAMA 283, 1583 (4%)
(1995): Chaisson RE, Infections in Medicine 12, 48
(1989): Fass RJ+, Am J Med 87, 164S
(1989): Modai J, Am J Med 87, 243S
(1989): Rahm V+, Scand J Infect Dis 60, 120
(1989): Schacht P+, Am J Med 87, 98S
(1988): Sanders WE, Rev Infect Dis 10, 528
(1988): Schacht P+, Infection 16, S29
Stevens–Johnson syndrome (